登录查看更多内容

Efanesoctocog Alfa

Connect2Clinic

An end-to-end Practice Management Platform that makes your In-Clinic & Online practice seamless!

发布日期: 2023年5月18日

Efanesoctocog alfa (ALTUVIIIO) is a recombinant Factor VIII concentrate used to treat hemophilia A. Developed by Bioverativ Therapeutics and Swedish Orphan Biovitrum, it was approved in the USA in February 2023. It can be used for routine prophylaxis, on-demand treatment of bleeding episodes, and perioperative management. This article outlines the key milestones in its development.

Read complete article here:

https://mu.connect2clinic.com/doctor/description/med-of-the-day/9ca24b6e-bbfd-4696-9e66-dbae1eb52f4c

Med Updates | Connect2Clinic

1,166 位关注者

要查看或添加评论，请登录

Connect2Clinic的更多文章

2025年3月6日

Dental caries prevalence and severity in children with ASD

This systematic review and meta-analysis examined the prevalence of dental caries in children and adolescents with and…
2025年3月4日

Association of herpes simplex virus infection and vitiligo

This study examined the association between herpes simplex virus infection and vitiligo using a nationwide health…
2025年2月27日

Association between food deserts and IBD severity at diagnosis in pediatrics

This study evaluated food deserts' impact on inflammatory bowel disease (IBD) severity. Among 98 patients, 15% lived in…
2025年2月25日

Comparative efficacy of multiple non-invasive brain stimulation to treat major depressive disorder in older patients

This study compared non-invasive brain stimulation (NIBS) techniques for treating major depressive disorder (MDD) in…

1 条评论
2025年2月20日

Speech therapy reduces laryngeal obstruction in exercise-induced laryngeal obstruction patients

This study evaluated speech therapy for exercise-induced laryngeal obstruction (EILO). Among 28 patients, therapy…
2025年2月18日

Genetic basis of lupus nephritis in longitudinal systemic lupus erythematosus

This study explored the genetic basis of lupus nephritis (LN) in a longitudinal cohort of subphenotyped SLE patients…
2025年2月13日

Improving diagnosis of oral mucosal disorders in dermatology

Many dermatologic and systemic disorders manifest in the oral mucosa, yet training in this area is limited…
2025年2月11日

Comparing facial scanners for virtual dental patient accuracy

This study evaluated the accuracy of virtual dental patients (VDPs) using industrial and smartphone facial scanners…
2025年2月6日

Impact of glycemic control on plaque vulnerability in acute myocardial infarction patients

This study examines the link between glycemic control and non-culprit lesion (NCL) characteristics in acute myocardial…
2025年2月4日

Congenital cytomegalovirus: Evaluation, management, and counseling update

This review updates obstetrician–gynecologists on congenital cytomegalovirus (CMV) evaluation and management. CMV, the…

See all articles

社区洞察

Chemical Engineering

What is the best way to predict the pharmacokinetics of a drug?
Technological Innovation

What are the most effective market research methods for evaluating a new biotech product's market size?
Sample Preparation

How do you reduce sample variability and bias in biomarker studies?
Laboratory Management

You're setting up a new laboratory. Which reagents should you invest in?
Materials Science

How can you ensure that drug delivery nanoparticles are biocompatible?
Market Access

How do you assess the value proposition of a new drug for different payer segments?
Materials Science

How can you design a nanomaterial for targeted drug delivery while minimizing adverse effects?
Laboratory Management

How can you validate PCR assays for clinical or diagnostic applications?
Biotechnology

How can you improve your ELISA assay skills?
Healthcare Information Technology (HIT)

How do you collaborate and communicate with other stakeholders and organizations using RxNorm?

其他会员也浏览了

An efficient and mild preparation of terminal alkynes from alkenyl triflates

ATLANCHIM PHARMA 1 年
?? Exciting News! Huscience Achieves Global Central Lab Standards with ISO 17025 Accreditation ??

Huscience 6 个月
Merck KGaA suffers major blow as MS drug fails in late-stage trials

Rizochem Pharmaceuticals 1 年
8th AMR Conference 2024 in Basel/Switzerland

Thomas Winter 1 年
An efficient and mild preparation of terminal alkynes from alkenyl triflates

Jacques Lebreton 1 年
Raloxifene Hydrochloride API.

Revanth Kothoju 3 年
Protalix Looks Beyond Biobetters

Daniel Levine 5 年
Getting Misfolding Proteins to Shape Up

Daniel Levine 5 年
"...roughly 18 months from target discovery to preclinical candidate nomination..."

Ken Wasserman 12 个月
PvP Takes a Unique Approach to Treating an Autoimmune Disease

Daniel Levine 7 年

Med Updates | Connect2Clinic

1,166 位关注者

Connect2Clinic的更多文章

Dental caries prevalence and severity in children with ASD

Association of herpes simplex virus infection and vitiligo

Association between food deserts and IBD severity at diagnosis in pediatrics

Comparative efficacy of multiple non-invasive brain stimulation to treat major depressive disorder in older patients

Speech therapy reduces laryngeal obstruction in exercise-induced laryngeal obstruction patients

Genetic basis of lupus nephritis in longitudinal systemic lupus erythematosus

Improving diagnosis of oral mucosal disorders in dermatology

Comparing facial scanners for virtual dental patient accuracy

Impact of glycemic control on plaque vulnerability in acute myocardial infarction patients

Congenital cytomegalovirus: Evaluation, management, and counseling update

社区洞察

其他会员也浏览了

An efficient and mild preparation of terminal alkynes from alkenyl triflates

?? Exciting News! Huscience Achieves Global Central Lab Standards with ISO 17025 Accreditation ??

Merck KGaA suffers major blow as MS drug fails in late-stage trials

8th AMR Conference 2024 in Basel/Switzerland

An efficient and mild preparation of terminal alkynes from alkenyl triflates

Raloxifene Hydrochloride API.

Protalix Looks Beyond Biobetters

Getting Misfolding Proteins to Shape Up

"...roughly 18 months from target discovery to preclinical candidate nomination..."

PvP Takes a Unique Approach to Treating an Autoimmune Disease